Annex Advisory Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.27M Sell
28,619
-5,431
-16% -$1.27M 0.12% 90
2026
Q1
$8.32M Buy
34,050
+656
+2% +$153K 0.16% 87
2025
Q4
$6.91M Buy
33,394
+394
+1% +$77.9K 0.13% 100
2025
Q3
$6.12M Sell
33,000
-795
-2% -$136K 0.13% 91
2025
Q2
$5.16M Buy
33,795
+357
+1% +$54.9K 0.12% 87
2025
Q1
$5.55M Buy
33,438
+1,735
+5% +$271K 0.16% 84
2024
Q4
$4.58M Buy
31,703
+811
+3% +$126K 0.14% 89
2024
Q3
$5.01M Buy
30,892
+213
+0.7% +$33.9K 0.16% 85
2024
Q2
$4.48M Sell
30,679
-2,609
-8% -$388K 0.16% 83
2024
Q1
$5.27M Sell
33,288
-979
-3% -$156K 0.19% 80
2023
Q4
$5.37M Sell
34,267
-1,822
-5% -$279K 0.22% 73
2023
Q3
$5.62M Sell
36,089
-1,288
-3% -$213K 0.34% 60
2023
Q2
$6.19M Buy
37,377
+297
+0.8% +$47.9K 0.34% 57
2023
Q1
$5.75M Sell
37,080
-122
-0.3% -$19.7K 0.31% 51
2022
Q4
$6.57M Sell
37,202
-1,062
-3% -$183K 0.37% 45
2022
Q3
$6.25M Sell
38,264
-504
-1% -$85.3K 0.42% 42
2022
Q2
$6.88M Buy
38,768
+1,002
+3% +$179K 0.5% 39
2022
Q1
$6.69M Buy
37,766
+84
+0.2% +$14.3K 0.49% 42
2021
Q4
$6.45M Buy
37,682
+8,643
+30% +$1.41M 0.44% 38
2021
Q3
$4.69M Buy
29,039
+1,608
+6% +$274K 0.38% 44
2021
Q2
$4.52M Buy
27,431
+912
+3% +$151K 0.37% 48
2021
Q1
$4.36M Buy
26,519
+509
+2% +$82.4K 0.42% 40
2020
Q4
$4.09M Buy
26,010
+1,294
+5% +$191K 0.4% 37
2020
Q3
$3.68M Buy
24,716
+5,868
+31% +$868K 0.47% 23
2020
Q2
$2.65M Buy
18,848
+10,777
+134% +$1.57M 0.37% 34
2020
Q1
$1.06M Buy
8,071
+4,236
+110% +$601K 0.15% 67
2019
Q4
$559K Buy
3,835
+509
+15% +$69K 0.07% 82
2019
Q3
$430K Buy
3,326
+231
+7% +$30.4K 0.06% 87
2019
Q2
$431K Buy
3,095
+89
+3% +$12.3K 0.06% 83
2019
Q1
$420K Buy
3,006
+133
+5% +$17.8K 0.06% 84
2018
Q4
$371K Sell
2,873
-25
-0.9% -$3.49K 0.06% 89
2018
Q3
$400K Buy
2,898
+218
+8% +$29K 0.06% 89
2018
Q2
$325K Sell
2,680
-322
-11% -$40.2K 0.06% 91
2018
Q1
$385K Sell
3,002
-7,436
-71% -$1.01M 0.07% 92
2017
Q4
$1.46M Buy
10,438
+1,105
+12% +$154K 0.28% 38
2017
Q3
$1.21M Buy
9,333
+539
+6% +$71.5K 0.25% 43
2017
Q2
$1.16M Buy
8,794
+5,676
+182% +$724K 0.26% 34
2017
Q1
$388K Buy
3,118
+105
+3% +$12.5K 0.1% 82
2016
Q4
$347K Buy
3,013
+394
+15% +$45.5K 0.08% 83
2016
Q3
$309K Sell
2,619
-99
-4% -$12K 0.08% 86
2016
Q2
$330K Buy
2,718
+212
+8% +$24.1K 0.09% 87
2016
Q1
$271K Sell
2,506
-239
-9% -$24.7K 0.08% 93
2015
Q4
$282K Sell
2,745
-275
-9% -$27.7K 0.08% 93
2015
Q3
$282K Buy
3,020
+327
+12% +$31.6K 0.09% 93
2015
Q2
$262K Buy
2,693
+156
+6% +$15.6K 0.08% 98
2015
Q1
$255K Buy
2,537
+358
+16% +$36.4K 0.08% 100
2014
Q4
$228K Buy
2,179
+28
+1% +$2.95K 0.07% 82
2014
Q3
$229K Sell
2,151
-253
-11% -$26.2K 0.08% 70
2014
Q2
$252K Buy
2,404
+95
+4% +$9.6K 0.09% 65
2014
Q1
$227K Sell
2,309
-85
-4% -$7.88K 0.08% 74
2013
Q4
$219K Sell
2,394
-19
-0.8% -$1.75K 0.08% 82
2013
Q3
$209K Buy
+2,413
New +$216K 0.1% 90

Other funds holding JNJ

Annex Advisory Services's JNJ Position: Q2 2026 in Review

Annex Advisory Services reduced its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, selling an estimated $1.27M and leaving 28,619 shares worth $7.27M. The position accounts for 0.12% of the portfolio, ranked #90.

Annex Advisory Services first reported a position in JNJ in Q3 2013 and has held it in 52 quarters since. The position peaked at $8.32M in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Annex Advisory Services held 28,619 shares of Johnson & Johnson worth $7.27M as of Q2 2026.
  • Annex Advisory Services sold 5,431 Johnson & Johnson shares in Q2 2026, an estimated $1.27M.
  • Johnson & Johnson made up 0.12% of Annex Advisory Services's portfolio in Q2 2026, its #90 holding.
  • Annex Advisory Services first reported a position in Johnson & Johnson in Q3 2013 and has held it in 52 quarters since.
  • Annex Advisory Services's Johnson & Johnson position peaked at $8.32M in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Annex Advisory Services's 13F filing for Q2 2026, filed 10 Jul 2026.